Epilepsy Cell Therapy NRTX-1001 Among Trio Of Drugs To Win EMA PRIME Designations

 
• By Neena Brizmohun
  
Brain Human Nervous System Illustration
NRTX-1001 is a cell therapy targeting drug-resistant mesial temporal lobe epilepsy (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pink Sheet